Shuang Dou
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Advanced biosensing and bioanalysis techniques 8
- RNA Interference and Gene Delivery 8
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 10
- Respiratory Support and Mechanisms 4
- Co-authors
- Jun Wang (15 shared papers)Tianmeng Sun (6 shared papers)Chengqiong Mao (8 shared papers)Menghua Xiong (4 shared papers)Yucai Wang (3 shared papers)Xianzhu Yang (9 shared papers)Feng Wang (1 shared paper)Jin‐Zhi Du (4 shared papers)
- Journals
- International Journal of COPD (8 papers)ACS Nano (4 papers)Journal of Controlled Release (3 papers)Advanced Healthcare Materials (2 papers)Molecular Therapy (1 paper)
- Partner nations
- ChinaUnited StatesVietnam
In The Last Decade
Shuang Dou
30 papers receiving 2.5k citations
Shuang Dou's Hit Papers
Peers
Comparison fields: 5 of 112
- Biomaterials 1.1k
- Biomedical Engineering 848
- Molecular Biology 1.3k
- Cancer Research 245
- Pharmaceutical Science 96
Countries citing papers authored by Shuang Dou
This map shows the geographic impact of Shuang Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuang Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuang Dou more than expected).
Fields of papers citing papers by Shuang Dou
This network shows the impact of papers produced by Shuang Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuang Dou. The network helps show where Shuang Dou may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuang Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer Cells Hit paper breakdown → | 2011 | 672 |
| 2 | 2011 | 355 | |
| 3 | 2011 | 263 | |
| 4 | 2011 | 214 | |
| 5 | 2012 | 163 | |
| 6 | 2012 | 127 | |
| 7 | 2014 | 91 | |
| 8 | 2013 | 61 | |
| 9 | 2015 | 52 | |
| 10 | 2014 | 49 | |
| 11 | 2009 | 47 | |
| 12 | 2013 | 41 | |
| 13 | 2008 | 41 | |
| 14 | 2018 | 38 | |
| 15 | 2012 | 38 | |
| 16 | 2014 | 36 | |
| 17 | 2024 | 30 | |
| 18 | 2016 | 25 | |
| 19 | 2016 | 24 | |
| 20 | 2018 | 20 |
About Shuang Dou
Shuang Dou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Biomaterials, Oncology and Cancer Research, having authored 32 papers that have together received 2.5k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers), Advanced biosensing and bioanalysis techniques (8 papers), RNA Interference and Gene Delivery (8 papers), MicroRNA in disease regulation (4 papers), Respiratory Support and Mechanisms (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Asthma and respiratory diseases (3 papers) and biodegradable polymer synthesis and properties (3 papers). The work is most often cited by research in Biomaterials (1.1k citations), Biomedical Engineering (848 citations), Molecular Biology (1.3k citations), Cancer Research (245 citations) and Pharmaceutical Science (96 citations). Shuang Dou has collaborated with scholars based in China, United States and Vietnam. Frequent co-authors include Jun Wang, Tianmeng Sun, Chengqiong Mao, Menghua Xiong, Yucai Wang, Xianzhu Yang, Feng Wang, Jin‐Zhi Du, Yandan Yao and Hongyan Long. Their work appears in journals such as International Journal of COPD, ACS Nano, Journal of Controlled Release, Advanced Healthcare Materials and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.